Survey of blood flow restriction therapy for rehabilitation in Sports Medicine patients.
Anterior cruciate ligament
Blood flow restriction
Non-operative management
Rehabilitation
Journal
Journal of orthopaedics
ISSN: 0972-978X
Titre abrégé: J Orthop
Pays: India
ID NLM: 101233220
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
07
02
2023
accepted:
12
03
2023
pmc-release:
01
04
2024
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
Blood flow restriction (BFR) therapy has demonstrated benefits across a spectrum of musculoskeletal injuries, including improved strength, endurance, function, and reduction in pain perception. There is, however, no standardized application of BFR therapy among orthopaedic surgeons within the United States (US). The indication and protocol for BFR therapy vary significantly across providers in the US. An online survey of 21 multiple-choice questions was sent to 3,281 surgeons listed on a large orthopaedic registry. A cross-sectional study was performed on all surgeons who successfully completed the questionnaire. Surgeons were queried on current or planned use of BFR, indications, contraindications, and peri-operative and non-operative management of sports-related injuries. Overall, 250 physicians completed the survey, with 149 (59.8%) reporting current BFR use and 75.2% initiating use in the last 1-5 years. Most protocols (78.8%) utilize the modality 2-3 times per week while 15.9% use it only once weekly. Anterior cruciate ligament reconstruction (ACLR) rehabilitation was the most reported indication for initiating BFR therapy (95.7%) along with medial patellofemoral ligament reconstruction (70.2%), multiligamentous knee reconstruction (68.8%), meniscus repair (62.4%), collateral ligament reconstruction (50.4%), Achilles tendon repairs (30.5%), and meniscectomy (27%). Only 36.5% reported using BFR after upper extremity procedures, such as distal biceps repair (19.7%), ulnar collateral ligament elbow reconstruction (17%), rotator cuff (16.8%), and shoulder labrum repair (15.3%). For non-operative injuries, 65.8% of surgeons utilized BFR. Of those not currently using BFR therapy, 33.3% intended to implement its use in the future. BFR therapy has increased in popularity with most physicians implementing its use in the last 5 years. BFR was commonly utilized after ACLR. BFR allows light-load resistance to simulate high-intensity resistance training. This study describes US orthopaedic surgeons' common practice patterns and patient populations that utilize BFR therapy.
Sections du résumé
Background
UNASSIGNED
Blood flow restriction (BFR) therapy has demonstrated benefits across a spectrum of musculoskeletal injuries, including improved strength, endurance, function, and reduction in pain perception. There is, however, no standardized application of BFR therapy among orthopaedic surgeons within the United States (US).
Hypothesis
UNASSIGNED
The indication and protocol for BFR therapy vary significantly across providers in the US.
Methods
UNASSIGNED
An online survey of 21 multiple-choice questions was sent to 3,281 surgeons listed on a large orthopaedic registry. A cross-sectional study was performed on all surgeons who successfully completed the questionnaire. Surgeons were queried on current or planned use of BFR, indications, contraindications, and peri-operative and non-operative management of sports-related injuries.
Results
UNASSIGNED
Overall, 250 physicians completed the survey, with 149 (59.8%) reporting current BFR use and 75.2% initiating use in the last 1-5 years. Most protocols (78.8%) utilize the modality 2-3 times per week while 15.9% use it only once weekly. Anterior cruciate ligament reconstruction (ACLR) rehabilitation was the most reported indication for initiating BFR therapy (95.7%) along with medial patellofemoral ligament reconstruction (70.2%), multiligamentous knee reconstruction (68.8%), meniscus repair (62.4%), collateral ligament reconstruction (50.4%), Achilles tendon repairs (30.5%), and meniscectomy (27%). Only 36.5% reported using BFR after upper extremity procedures, such as distal biceps repair (19.7%), ulnar collateral ligament elbow reconstruction (17%), rotator cuff (16.8%), and shoulder labrum repair (15.3%). For non-operative injuries, 65.8% of surgeons utilized BFR. Of those not currently using BFR therapy, 33.3% intended to implement its use in the future.
Conclusion
UNASSIGNED
BFR therapy has increased in popularity with most physicians implementing its use in the last 5 years. BFR was commonly utilized after ACLR.
Clinical relevance
UNASSIGNED
BFR allows light-load resistance to simulate high-intensity resistance training. This study describes US orthopaedic surgeons' common practice patterns and patient populations that utilize BFR therapy.
Identifiants
pubmed: 36969302
doi: 10.1016/j.jor.2023.03.007
pii: S0972-978X(23)00062-4
pmc: PMC10030811
doi:
Types de publication
Journal Article
Langues
eng
Pagination
47-52Informations de copyright
© 2023 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
There are no conflicts of interest to report.
Références
Clin Orthop Relat Res. 2020 Mar;478(3):593-606
pubmed: 31860546
Med Sci Sports Exerc. 2018 May;50(5):897-905
pubmed: 29266093
Int J Sports Phys Ther. 2020 Dec;15(6):882-891
pubmed: 33344004
Am J Sports Med. 2021 Aug;49(10):2716-2728
pubmed: 34110960
J Strength Cond Res. 2015 Apr;29(4):1071-6
pubmed: 25264670
J Sci Med Sport. 2016 Aug;19(8):669-75
pubmed: 26463594
Phys Ther. 2019 Aug 1;99(8):1010-1019
pubmed: 30951598
Sports Med. 2016 Jan;46(1):23-33
pubmed: 26446893
Clin J Sport Med. 2017 May;27(3):245-252
pubmed: 27749358
J Sport Rehabil. 2019 Nov 1;28(8):897-901
pubmed: 30300054
Acta Orthop Scand. 2003 Feb;74(1):62-8
pubmed: 12635796
Am J Sports Med. 2020 Mar;48(4):825-837
pubmed: 32167837
Sports Med. 2018 Feb;48(2):361-378
pubmed: 29043659
J Strength Cond Res. 2019 Jul;33 Suppl 1:S167-S179
pubmed: 30011262
Sports Health. 2019 Mar/Apr;11(2):149-156
pubmed: 30638439
J Clin Med. 2020 Dec 27;10(1):
pubmed: 33375515
Int J Sports Med. 2015 May;36(5):395-9
pubmed: 25700103
Am J Phys Med Rehabil. 2021 Apr 1;100(4):337-344
pubmed: 33727516
Sports Health. 2019 Jan/Feb;11(1):69-83
pubmed: 30475660
J Foot Ankle Surg. 2018 May - Jun;57(3):635-638
pubmed: 29477554
Phys Ther. 2019 Nov 25;99(11):1495-1500
pubmed: 31392999
Sports Med. 2019 Nov;49(11):1787-1805
pubmed: 31301034
Orthop J Sports Med. 2018 Dec 03;6(12):2325967118811063
pubmed: 30534575
Appl Physiol Nutr Metab. 2019 Feb;44(2):216-220
pubmed: 30001503
Sports Med. 2019 Jan;49(1):95-108
pubmed: 30306467
Am J Sports Med. 2020 Jun;48(7):1773-1785
pubmed: 31710505
Int J Sports Med. 2019 Sep;40(10):650-656
pubmed: 31342480
Phys Ther Sport. 2018 Nov;34:121-128
pubmed: 30268966
J Sports Sci. 2018 Jan;36(2):123-130
pubmed: 28143359
Br J Sports Med. 2017 Jul;51(13):1003-1011
pubmed: 28259850